miRNA expression was measured genome-wide in FFPE breast cancer tissues using Agilent miRNA assay[54] or Agilent SurePrint G3 Human miRNA microarray[55] in cohorts of 14 and 40 HER2-positive breast cancer patients. This evidence concerns the gene ERBB2 and breast cancer.